Canaccord Genuity Positive on GenMark Diagnostics (GNMK)

January 15, 2013 11:53 AM EST Send to a Friend
Get Alerts GNMK Hot Sheet
Price: $13.37 -0.22%

Rating Summary:
    5 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 14 | Down: 25 | New: 51
Trade GNMK Now!
Join SI Premium – FREE
Canaccord Genuity today reiterated a Buy rating on GenMark Diagnostics (NASDAQ: GNMK) and raised its price target to $14.00 (from $12.00).

"Given management's recent track record of executing, coupled with its long-term growth trajectory, we believe GNMK merits trading at the upper end of the MDx peer group P/S multiple (5x-7x)," said analyst Jeffrey Frelick.

With a strong start to the flu season, Frelick thinks GNMK should see good results from its RVP test.

For an analyst ratings summary and ratings history on GenMark Diagnostics (NASDAQ: GNMK) click here. For more ratings news on GenMark Diagnostics click here.

Shares of GenMark Diagnostics closed at $11.14 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS View, Analyst PT Change

Related Entities

Canaccord Genuity

Add Your Comment